Ellen Buckingham Penney, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dystonic Disorders | 5 | 2022 | 329 | 0.690 |
Why?
|
| Genetic Diseases, X-Linked | 6 | 2022 | 372 | 0.510 |
Why?
|
| Dystonia | 2 | 2022 | 363 | 0.310 |
Why?
|
| Huntington Disease | 4 | 2022 | 1124 | 0.230 |
Why?
|
| Transcription Factor TFIID | 2 | 2020 | 151 | 0.220 |
Why?
|
| TATA-Binding Protein Associated Factors | 2 | 2020 | 104 | 0.220 |
Why?
|
| Histone Acetyltransferases | 2 | 2020 | 336 | 0.200 |
Why?
|
| Histones | 2 | 2020 | 2599 | 0.180 |
Why?
|
| Hashimoto Disease | 1 | 2020 | 97 | 0.170 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 275 | 0.170 |
Why?
|
| Ear, Inner | 1 | 2002 | 420 | 0.150 |
Why?
|
| Hyponatremia | 1 | 2020 | 298 | 0.150 |
Why?
|
| Encephalitis | 1 | 2020 | 423 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 1061 | 0.100 |
Why?
|
| Retroelements | 2 | 2022 | 164 | 0.090 |
Why?
|
| Prefrontal Cortex | 1 | 2020 | 2147 | 0.090 |
Why?
|
| Introns | 2 | 2020 | 991 | 0.070 |
Why?
|
| Cell Division | 2 | 2003 | 4568 | 0.060 |
Why?
|
| Genome, Human | 1 | 2018 | 4420 | 0.060 |
Why?
|
| Lateral Ventricles | 1 | 2005 | 146 | 0.060 |
Why?
|
| Cell Aggregation | 1 | 2002 | 244 | 0.050 |
Why?
|
| Minisatellite Repeats | 2 | 2018 | 165 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 554 | 0.050 |
Why?
|
| Inflammation | 2 | 2020 | 10638 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 438 | 0.050 |
Why?
|
| Ornithine | 1 | 2020 | 78 | 0.050 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2020 | 61 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2002 | 964 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2020 | 4161 | 0.040 |
Why?
|
| Leukocyte Elastase | 1 | 2020 | 113 | 0.040 |
Why?
|
| Dyskinesias | 1 | 2020 | 78 | 0.040 |
Why?
|
| Gliosis | 1 | 2020 | 245 | 0.040 |
Why?
|
| Hair Cells, Auditory | 1 | 2002 | 361 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2020 | 683 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 2020 | 387 | 0.040 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2018 | 40 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2020 | 440 | 0.040 |
Why?
|
| Acetylation | 1 | 2020 | 1085 | 0.040 |
Why?
|
| Alu Elements | 1 | 2018 | 119 | 0.040 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 788 | 0.040 |
Why?
|
| Peroxidase | 1 | 2020 | 611 | 0.040 |
Why?
|
| Arm | 1 | 2020 | 589 | 0.040 |
Why?
|
| Autopsy | 1 | 2020 | 1020 | 0.040 |
Why?
|
| Extremities | 1 | 2002 | 865 | 0.040 |
Why?
|
| Chemokines | 1 | 2020 | 970 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2002 | 1701 | 0.030 |
Why?
|
| Sodium | 1 | 2020 | 1623 | 0.030 |
Why?
|
| Face | 1 | 2020 | 994 | 0.030 |
Why?
|
| Neurons | 3 | 2018 | 9338 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 748 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2005 | 285 | 0.030 |
Why?
|
| Astrocytes | 1 | 2020 | 1270 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1117 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 11366 | 0.030 |
Why?
|
| Microglia | 1 | 2020 | 1266 | 0.030 |
Why?
|
| Visual Cortex | 1 | 2000 | 1149 | 0.030 |
Why?
|
| Stem Cells | 1 | 2005 | 3567 | 0.020 |
Why?
|
| Haplotypes | 1 | 2018 | 2779 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 851 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2020 | 2107 | 0.020 |
Why?
|
| Tubulin | 2 | 2005 | 695 | 0.020 |
Why?
|
| Cell Survival | 1 | 2020 | 5882 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2915 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2018 | 2575 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2018 | 3494 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 4462 | 0.020 |
Why?
|
| Family | 1 | 2018 | 3147 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 1736 | 0.020 |
Why?
|
| Base Sequence | 1 | 2018 | 12797 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2018 | 13033 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3597 | 0.020 |
Why?
|
| Brain | 2 | 2021 | 26385 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 5853 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2005 | 126 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19229 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12959 | 0.020 |
Why?
|
| Humans | 9 | 2022 | 744343 | 0.010 |
Why?
|
| Male | 5 | 2022 | 350118 | 0.010 |
Why?
|
| Trinucleotide Repeats | 1 | 2003 | 261 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2003 | 528 | 0.010 |
Why?
|
| Aged | 4 | 2020 | 163280 | 0.010 |
Why?
|
| Cell Count | 1 | 2005 | 1856 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 57776 | 0.010 |
Why?
|
| Adult | 3 | 2022 | 214055 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 1581 | 0.010 |
Why?
|
| Mice | 2 | 2002 | 81183 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2000 | 647 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 1950 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 40561 | 0.010 |
Why?
|
| Neuroglia | 1 | 2000 | 927 | 0.010 |
Why?
|
| Female | 4 | 2020 | 380194 | 0.010 |
Why?
|
| Middle Aged | 3 | 2020 | 213383 | 0.010 |
Why?
|
| Animals | 2 | 2002 | 168757 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2000 | 3920 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 3507 | 0.010 |
Why?
|
| Peptides | 1 | 2000 | 4409 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 9734 | 0.000 |
Why?
|
| Calcium | 1 | 2000 | 5756 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2003 | 21746 | 0.000 |
Why?
|
| Models, Biological | 1 | 2000 | 9583 | 0.000 |
Why?
|
| Age Factors | 1 | 2000 | 18370 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 2000 | 5751 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2000 | 23403 | 0.000 |
Why?
|